Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Pain Pract. 2015 Jan 12;16(3):282–293. doi: 10.1111/papr.12279

Table 2.

Analgesic drugs consumed within 24 hours before testing procedures (N=25)

Fiber Function (number of subjects) [Mechanism] Drug Class Drug Name (subject code number)1 Dose mg/24 hrs1
Normal & abnormal mechanical and thermal (n=8) [mixed sensitization] Non-opioid Acetaminophen (12/6, 24) 1300/0
NSAID Acetylsalicylic acid (1) 325
Naproxen (13/16) 500/0
Ibuprophen (24, 2, 14) 0
Step 2 opioid Tramadol (16/14) 50/200
Hydrocodone (2/13/24) 0/10/0
Step 3 opioid Morphine – Injectable (13) 45
Morphine-immediate release (9) 15
Morphine-sustained release (9) 30
Methadone (14) 40
Hydromorphone (14) 0
Adjuvant Amitriptyline (14) 75
carbamazepine (14) 200
Normal mechanical; Abnormal thermal (n=1) [peripheral sensitization] Step 3 opioid Hydromorphone –injectable (22) 0
Abnormal mechanical and thermal (n=15) [central sensitization] Non-opioid Acetaminophen (5, 10, 17, 25/23/19) 0/650/1,500
Ibuprophen (4/17, 23/25) 3200/0/800
Acetylsalicylic acid (8) 650
Step 2 opioid Hydrocodone (4/11/21) 25/UK/0
Codeine (23) 0
Tylenol with codeine or hydrocodone (5, 6, 7, 8, 17, 21, 23) 0
Tramadol (10/25) 200/0
Tylenol with codeine (19) 90
Step 3 opioid Morphine-immediate release (5) 0
Fentanyl patch (10) 375
Morphine -immediate release (23) 0
Morphine -injectable (23) 0
Morphine -sustained release (8, 18, 23) 0
Oxycodone -controlled release (3) 10
Adjuvant Amitriptyline (20) 5
All normal (n=1) [No sensitization] Non-opioid Acetaminophen (15) 650
NSAID Ibuprophen (15) 800
Step 3 opioid Morphine-immediate release (15) 0

Key:

1

/ separates code numbers corresponding to doses in the last column